Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster
Investigation of the Effect of Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster in Patients With Lung Cancer
1 other identifier
interventional
78
1 country
1
Brief Summary
This study was designed as a randomized, control group, experimental study to examine the effect of Active Cycle of Breathing Techniques application on respiratory distress symptom cluster in patients with lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJune 24, 2025
June 1, 2025
8 months
April 13, 2023
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Dyspnea Level
The level of dyspnea will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not. The Turkish version of the Cancer Dyspnea Scale, the Turkish Validity and Reliability of which was made by Bitek and Tokem in 2021, will be used to measure the level of dyspnea.
28 Days
Fatigue Level
The level of fatigue will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not. The Turkish version of the Hirai Cancer Fatigue Scale, the Turkish validity and reliability of which was made by Mencel in 2021, will be used to measure the level of fatigue.
28 days
Health-related quality of life in chronic cough
The level of health-related quality of life in chronic cough will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not. The Turkish version of the Leicester Cough Questionnaire (LCQ), the Turkish validity and reliability of which was made by Gonen ve Havlucu in 2014, will be used to measure the level of health-related quality of life in chronic cough.
28 days
Study Arms (2)
Active Cycle Of Breathing Techniques Group
EXPERIMENTALPatients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.
Control group
NO INTERVENTIONNo intervention will be given to the patients in the control group.
Interventions
Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.
Eligibility Criteria
You may qualify if:
- Being 18 years or older
- Being diagnosed with stage IV non-small cell lung cancer
- Being diagnosed with lung cancer in the type of adenocarcinoma and squamous cell carcinoma
- Receiving outpatient chemotherapy treatment
- Receiving the first course of chemotherapy treatment
- ECOG Performance Scale Score \< 3
- Having all the symptoms of dyspnea, cough, and fatigue
- Not having a cognitive disorder or a diagnosed psychiatric illness
- Being able to speak Turkish
- Volunteering to participate in the research
You may not qualify if:
- Experiencing a chronic obstructive pulmonary disease (COPD) exacerbation in the last 4 weeks
- Having an active lung infection
- Not volunteering to participate in the research
- Not having dyspnea, cough, and fatigue symptoms
- Not speaking Turkish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maltepe Universitylead
- Saglik Bilimleri Universitesicollaborator
Study Sites (1)
Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Doğa Ulcay, Msc
Maltepe University
- PRINCIPAL INVESTIGATOR
Semiha Akın, Prof.
University of Health science
- PRINCIPAL INVESTIGATOR
Akın Öztürk, Specialist
Süreyyapaşa Chest Diseases and Thoracic Surgery Training And Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 13, 2023
First Posted
May 30, 2023
Study Start
October 1, 2023
Primary Completion
May 30, 2024
Study Completion
June 30, 2024
Last Updated
June 24, 2025
Record last verified: 2025-06